MYOV Annual EBITDA
-$183.89 M
+$58.03 M+23.99%
31 March 2022
Summary:
As of February 5, 2025, MYOV annual earnings before interest, taxes, depreciation & amortization is -$183.89 million, with the most recent change of +$58.03 million (+23.99%) on March 31, 2022. During the last 3 years, it has risen by +$79.93 million (+30.30%).MYOV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYOV Quarterly EBITDA
-$49.42 M
-$17.54 M-55.01%
31 December 2022
Summary:
As of February 5, 2025, MYOV quarterly earnings before interest, taxes, depreciation & amortization is -$49.42 million, with the most recent change of -$17.54 million (-55.01%) on December 31, 2022. Over the past year, it has increased by +$9.47 million (+16.08%).MYOV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYOV TTM EBITDA
-$140.43 M
+$9.47 M+6.32%
31 December 2022
Summary:
As of February 5, 2025, MYOV TTM earnings before interest, taxes, depreciation & amortization is -$140.43 million, with the most recent change of +$9.47 million (+6.32%) on December 31, 2022. Over the past year, it has increased by +$68.65 million (+32.83%).MYOV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYOV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.0% | +16.1% | +32.8% |
| 3 y3 years | +30.3% | +39.2% | +50.1% |
| 5 y5 years | -120.3% | -20.5% | +50.1% |
MYOV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +120.4% | +635.6% | +719.5% |
Myovant Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | -$49.42 M(+55.0%) | -$140.43 M(-6.3%) |
| Sept 2022 | - | -$31.88 M(+294.6%) | -$149.90 M(+10.7%) |
| June 2022 | - | -$8.08 M(-84.2%) | -$135.45 M(-26.3%) |
| Mar 2022 | -$183.89 M(-24.0%) | -$51.04 M(-13.3%) | -$183.89 M(-12.0%) |
| Dec 2021 | - | -$58.89 M(+237.8%) | -$209.07 M(-5.8%) |
| Sept 2021 | - | -$17.43 M(-69.2%) | -$221.93 M(-17.5%) |
| June 2021 | - | -$56.52 M(-25.9%) | -$268.99 M(+11.2%) |
| Mar 2021 | -$241.92 M(-11.6%) | -$76.23 M(+6.2%) | -$241.92 M(+5.8%) |
| Dec 2020 | - | -$71.75 M(+11.3%) | -$228.59 M(-4.0%) |
| Sept 2020 | - | -$64.49 M(+118.9%) | -$238.08 M(-0.7%) |
| June 2020 | - | -$29.45 M(-53.2%) | -$239.81 M(-12.4%) |
| Mar 2020 | -$273.80 M | -$62.90 M(-22.6%) | -$273.80 M(-2.8%) |
| Dec 2019 | - | -$81.25 M(+22.7%) | -$281.54 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$66.22 M(+4.4%) | -$269.19 M(+0.8%) |
| June 2019 | - | -$63.44 M(-10.2%) | -$266.98 M(+1.2%) |
| Mar 2019 | -$263.82 M(+87.4%) | -$70.64 M(+2.5%) | -$263.82 M(+9.6%) |
| Dec 2018 | - | -$68.89 M(+7.6%) | -$240.60 M(+13.1%) |
| Sept 2018 | - | -$64.00 M(+6.2%) | -$212.74 M(+18.9%) |
| June 2018 | - | -$60.28 M(+27.1%) | -$178.85 M(+27.4%) |
| Mar 2018 | -$140.75 M(+68.7%) | -$47.43 M(+15.6%) | -$140.41 M(+22.4%) |
| Dec 2017 | - | -$41.02 M(+36.2%) | -$114.72 M(+40.3%) |
| Sept 2017 | - | -$30.12 M(+37.9%) | -$81.74 M(+40.1%) |
| June 2017 | - | -$21.84 M(+0.5%) | -$58.34 M(+8.8%) |
| Mar 2017 | -$83.45 M | -$21.74 M(+170.1%) | -$53.64 M(+68.1%) |
| Dec 2016 | - | -$8.05 M(+19.7%) | -$31.90 M(+33.7%) |
| Sept 2016 | - | -$6.72 M(-60.8%) | -$23.85 M(+39.2%) |
| June 2016 | - | -$17.14 M | -$17.14 M |
FAQ
- What is Myovant Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Myovant Sciences?
- What is Myovant Sciences annual EBITDA year-on-year change?
- What is Myovant Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Myovant Sciences?
- What is Myovant Sciences quarterly EBITDA year-on-year change?
- What is Myovant Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Myovant Sciences?
- What is Myovant Sciences TTM EBITDA year-on-year change?
What is Myovant Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MYOV is -$183.89 M
What is the all time high annual EBITDA for Myovant Sciences?
Myovant Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$83.45 M
What is Myovant Sciences annual EBITDA year-on-year change?
Over the past year, MYOV annual earnings before interest, taxes, depreciation & amortization has changed by +$58.03 M (+23.99%)
What is Myovant Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MYOV is -$49.42 M
What is the all time high quarterly EBITDA for Myovant Sciences?
Myovant Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.72 M
What is Myovant Sciences quarterly EBITDA year-on-year change?
Over the past year, MYOV quarterly earnings before interest, taxes, depreciation & amortization has changed by +$9.47 M (+16.08%)
What is Myovant Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MYOV is -$140.43 M
What is the all time high TTM EBITDA for Myovant Sciences?
Myovant Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$17.14 M
What is Myovant Sciences TTM EBITDA year-on-year change?
Over the past year, MYOV TTM earnings before interest, taxes, depreciation & amortization has changed by +$68.65 M (+32.83%)